CLRD — Clearday Share Price
0.000.00%
Last trade - 00:00- $0.18m
- -$43.41m
- $12.49m
- 21
- 87
- 18
- 37
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0 | ||
| Price to Tang. Book | 0.01 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.02 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -37.8% | ||
| Operating Margin | -15.14% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.56 | 0.55 | 0.18 | 12.88 | 12.49 | n/a | n/a | 94.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Clearday, Inc. is engaged in providing technologies and care solutions. The Company has developed a purpose-built longevity-tech platform that addresses the pressing operational and care gaps in the longevity care market. Its platform leverages its longevity care experience in the challenging senior care venues (Memory and Alzheimer's treatment.) The Company’s platform enables a dedicated connection between families and communities that can provide new insights, monitoring, and engagement opportunities through its numerous touchpoints, including live events and therapies, group calls, and management of OT/PT and treatment adherence. Its Clearday Labs develops products and services to support older Americans ability to age in the right place. The Clearday Labs initiatives include the development of digital and robotic services in its Longevity-tech platform. It provides exemplary care for older Americans facing dementia and other lifestyle-limiting physical and cognitive issues.
Directors
- James Walesa CHM (59)
- John Bergeron CFO (64)
- Linda Carrasco CEX
- B. J. Parrish COO
- Richard Morris EVP
- Gary Sawina EVP
- Adam Shelton VPR (53)
- Richard Levychin DRC (62)
- Elizabeth Caveness IND
- Alan Channing IND
- Jeffrey Coleman IND
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- May 11th, 1987
- Public Since
- March 9th, 1993
- No. of Shareholders
- 425
- No. of Employees
- 225
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 27,058,607
- Address
- 15511 W. State Hwy 71, Suite 110-105, AUSTIN, 78738
- Web
- https://myclearday.com/
- Phone
- +1 5126507775
- Auditors
- Turner, Stone & Company
Upcoming Events for CLRD
Q1 2024 Clearday Inc Earnings Release
Q2 2024 Clearday Inc Earnings Release
Q3 2024 Clearday Inc Earnings Release
Similar to CLRD
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
ACI Global
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
FAQ
What is the Clearday share price?
As of Today at 19:59 UTC, shares in Clearday are trading at $0.01. This share price information is delayed by 15 minutes.
How has the Clearday share price performed this year?
Shares in Clearday last closed at $0.01 and the price had moved by -99.13% over the past 365 days. In terms of relative price strength the Clearday share price has underperformed the S&P500 Index by -99.33% over the past year.
What are the analyst and broker recommendations for Clearday?
The overall consensus recommendation for Clearday is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Clearday dividend yield?
Clearday does not currently pay a dividend.
Does Clearday pay a dividend?
Clearday does not currently pay a dividend.
When does Clearday next pay dividends?
Clearday does not currently pay a dividend.
How do I buy Clearday shares?
To buy shares in Clearday you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Clearday?
As of the previous close price of $0.01, shares in Clearday had a market capitalisation of $0.18m.
Where are Clearday shares listed?
Here are the trading details for Clearday:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CLRD
What kind of share is Clearday?
Based on an overall assessment of its quality, value and momentum Clearday is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Clearday share price forecast for 2024?
The analyst consensus target price for shares in Clearday is $9.00. That is 138361.54% above the last closing price of $0.01.
Analysts covering Clearday currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Clearday share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Clearday. Over the past six months, its share price has underperformed the S&P500 Index by -97.93%.
As of the last closing price of $0.01, shares in Clearday were trading -98.89% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Clearday PE Ratio?
The Clearday PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Clearday?
Clearday's management team is headed by:
- James Walesa - CHM
- John Bergeron - CFO
- Linda Carrasco - CEX
- B. J. Parrish - COO
- Richard Morris - EVP
- Gary Sawina - EVP
- Adam Shelton - VPR
- Richard Levychin - DRC
- Elizabeth Caveness - IND
- Alan Channing - IND
- Jeffrey Coleman - IND